Rating Change
Citizens analysts reiterated a Market Outperform rating on National Research Corporation (NASDAQ:NRC) on July 29, 2026.
reiterateNASDAQ:NRC
Citizens Reiterates Market Outperform Rating on National Research Corporation (NRC)
Rating Change Citizens analysts reiterated a Market Outperform rating on National Research Corporation (NASDAQ:NRC) on July 29, 2026. Market Context National Research Corporation…
Market Context
National Research Corporation operates in the Healthcare sector. The stock currently trades at $18.30 with a market capitalization of $397.5M.
Analyst coverage from Citizens provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for National Research Corporation.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for National Research Corporation
Among the 2 most recent ratings: 2 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 29, 2026 | Citizens | Market Outperform | N/A |
| Jun 22, 2026 | Citizens | Market Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View NRC Stock Page
Frequently Asked Questions
What does a Market Outperform rating mean for NRC?
A Market Outperform rating from Citizens reflects the analyst's outlook on National Research Corporation (NASDAQ:NRC). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the NRC forecast page.